Skip to main content

Table 1 Clinicopathological parameters of 64 ovarian cancer patients

From: HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

Characteristics

No

Age, years

 ≥ 50

42

 < 50

22

Histological type

 Serous Adenocarcinoma

50

 Mucinous Adenocarcinoma

2

 Endometrioid Adenocarcinoma

6

 Clear Cell Carcinoma

5

 Transitional Cell Carcinoma

1

FIGO stage

 I

9

 II

6

 III

36

 IV

13

Differentiation

 Poor

27

 Moderate

24

 Well

13

Ascites

 + 

11

 −

53

Vessel Invasion

 + 

3

 −

61

Lymph Node

 + 

8

 −

56

Platinum Sensitivity

 Sensitive

50

 Resistance

14

Relapse

 + 

27

 −

37